Chitomi Hasebe

859 total citations
29 papers, 304 citations indexed

About

Chitomi Hasebe is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Chitomi Hasebe has authored 29 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hepatology, 17 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Chitomi Hasebe's work include Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (8 papers). Chitomi Hasebe is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Hepatitis C virus research (10 papers) and Hepatitis B Virus Studies (8 papers). Chitomi Hasebe collaborates with scholars based in Japan, Greece and Spain. Chitomi Hasebe's co-authors include Yutaka Kohgo, Motohiro Shindo, Katsuyuki Hirai, Yoshihiro Torimoto, Noriyasu Taya, Masayuki Kurosaki, Namiki Izumi, Hiroyuki Kimura, Isao Sakaida and Akira Kaneko and has published in prestigious journals such as Clinical Infectious Diseases, Scientific Reports and British Journal of Haematology.

In The Last Decade

Chitomi Hasebe

26 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chitomi Hasebe Japan 10 223 212 47 46 30 29 304
Satoyoshi Yamashita Japan 10 166 0.7× 141 0.7× 49 1.0× 36 0.8× 34 1.1× 21 270
Zhaoxia Tan China 11 180 0.8× 170 0.8× 29 0.6× 39 0.8× 29 1.0× 27 353
Barbara Lei Italy 8 143 0.6× 153 0.7× 15 0.3× 49 1.1× 35 1.2× 9 257
Ming‐Tsung Lin Taiwan 14 298 1.3× 315 1.5× 40 0.9× 37 0.8× 126 4.2× 34 483
Toshie Mashiba Japan 11 236 1.1× 226 1.1× 25 0.5× 72 1.6× 43 1.4× 27 356
Carl Janssen Belgium 6 82 0.4× 140 0.7× 25 0.5× 56 1.2× 25 0.8× 7 255
Chang Don Lee South Korea 12 291 1.3× 304 1.4× 19 0.4× 16 0.3× 53 1.8× 36 390
Abdelrahman Kobtan Egypt 10 256 1.1× 223 1.1× 46 1.0× 29 0.6× 120 4.0× 26 387
Bhupinder S. Anand United States 7 238 1.1× 272 1.3× 24 0.5× 16 0.3× 33 1.1× 11 350
Ming‐Yen Hsieh Taiwan 6 245 1.1× 213 1.0× 15 0.3× 22 0.5× 11 0.4× 13 284

Countries citing papers authored by Chitomi Hasebe

Since Specialization
Citations

This map shows the geographic impact of Chitomi Hasebe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chitomi Hasebe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chitomi Hasebe more than expected).

Fields of papers citing papers by Chitomi Hasebe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chitomi Hasebe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chitomi Hasebe. The network helps show where Chitomi Hasebe may publish in the future.

Co-authorship network of co-authors of Chitomi Hasebe

This figure shows the co-authorship network connecting the top 25 collaborators of Chitomi Hasebe. A scholar is included among the top collaborators of Chitomi Hasebe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chitomi Hasebe. Chitomi Hasebe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Itakura, Jun, Masayuki Kurosaki, Satoru Kakizaki, et al.. (2020). Features of resistance-associated substitutions after failure of multiple direct-acting antiviral regimens for hepatitis C. JHEP Reports. 2(5). 100138–100138. 8 indexed citations
2.
Kaneko, Shun, Masayuki Kurosaki, Kouji Joko, et al.. (2020). Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score. Scientific Reports. 10(1). 13021–13021. 15 indexed citations
3.
Tamaki, Nobuharu, Masayuki Kurosaki, Yutaka Yasui, et al.. (2020). Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus. Clinical Infectious Diseases. 73(9). e3349–e3354. 25 indexed citations
4.
Tamaki, Nobuharu, Masayuki Kurosaki, Atsunori Kusakabe, et al.. (2017). Hepatitis B surface antigen reduction by switching from long‐term nucleoside/nucleotide analogue administration to pegylated interferon. Journal of Viral Hepatitis. 24(8). 672–678. 20 indexed citations
5.
Sawada, Koji, Shunsuke Nakajima, Masami Abe, et al.. (2014). Effectiveness of pazopanib for postoperative recurrence of granulocyte colony-stimulating factor-producing primary hepatic angiosarcoma. International Cancer Conference Journal. 4(1). 41–47. 1 indexed citations
6.
7.
Okita, Kiwamu, Seiji Kawazoe, Chitomi Hasebe, et al.. (2013). Dose‐finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double‐blind, placebo‐controlled trial. Hepatology Research. 44(1). 83–91. 51 indexed citations
8.
Taya, Noriyasu, Yoshihiro Torimoto, Motohiro Shindo, et al.. (2000). Fas‐mediated apoptosis of peripheral blood mononuclear cells in patients with hepatitis C. British Journal of Haematology. 110(1). 89–97. 55 indexed citations
9.
Ohsaki, Yoshinobu, Shinobu Osanai, Yutaka Nishigaki, et al.. (2000). Extensively Calcified Hemangioma of the Diaphragm with Increased 99mTc-Hydroxymethylene Diphosphonate Uptake.. Internal Medicine. 39(7). 576–578. 8 indexed citations
10.
Inoue, Mitsutaka, Akihiro Matsumoto, T. Kawashima, et al.. (1999). Hepatocellular carcinoma developed in a patient with chronic hepatitis C after the disappearance of hepatitis C virus due to interferon therapy.. PubMed. 46(28). 2554–60. 10 indexed citations
11.
Hasebe, Chitomi. (1994). Progression of type C chronic hepatitis observed by laparoscopy using dye dispersing method.. Kanzo. 35(4). 279–288. 2 indexed citations
12.
Sekiya, Chihiro, Yoshihiro Torimoto, Masami Mizuno, et al.. (1994). Importance of cytotoxic T lymphocytes in the rejection of transplanted hepatocellular carcinoma. Journal of Gastroenterology. 29(3). 282–288. 1 indexed citations
13.
Sekiya, Chihiro, et al.. (1994). Characteristics of the PIVKA-II found in hepatocellular carcinoma, investigation using monoclonal antibodies MU-3 and 19B7. International Hepatology Communications. 2(5). 277–284. 4 indexed citations
14.
15.
16.
Suzuki, Hiroko, Yuji Ishikawa, Akira Uehara, et al.. (1989). A case of primary biliary cirrhosis at the precirrhotic stage which developed hepatic encephalopathy caused by a porto-systemic shunt.. Kanzo. 30(6). 678–685. 1 indexed citations
17.
Hasebe, Chitomi, Chihiro Sekiya, Yuji Ishikawa, et al.. (1986). LAPAROSCOPIC FINDINGS OF NON-B CHRONIC HEPATITIS AND ITS PROGRESSION. Acta gastro-enterologica belgica. 28(6). 1202–1213. 2 indexed citations
18.
Yazaki, Yasuyuki, Yuji Ishikawa, Masataka Yamada, et al.. (1986). STUDIES ON VARIOUS ESOPHAGEAL LESIONS DUE TO PARAVARICEAL INJECTIONS OF 5% ETHANOLAMINE OLEATE DURING ENDOSCOPIC INJECTION SCLEROTHERAPY OF ESOPHAGEAL VARICES. Acta gastro-enterologica belgica. 28(10). 2257–2267. 1 indexed citations
19.
Takahashi, Atsushi, Chihiro Sekiya, Yasuyuki Yazaki, et al.. (1986). [Hepatic GOT and GPT activities in patients with various liver diseases--especially alcoholic liver disease].. PubMed. 61(3). 431–6. 6 indexed citations
20.
Hasebe, Chitomi, Chihiro Sekiya, Hitoshi Satoh, et al.. (1984). A case of .ALPHA.-fetoprotein-producing gallbladder carcinoma.. Kanzo. 25(9). 1180–1186. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoyoshi Yamashita Breakdown of academic impact, for papers by Zhaoxia Tan Breakdown of academic impact, for papers by Barbara Lei Breakdown of academic impact, for papers by Ming‐Tsung Lin Breakdown of academic impact, for papers by Toshie Mashiba Breakdown of academic impact, for papers by Carl Janssen Breakdown of academic impact, for papers by Chang Don Lee Breakdown of academic impact, for papers by Abdelrahman Kobtan Breakdown of academic impact, for papers by Bhupinder S. Anand Breakdown of academic impact, for papers by Ming‐Yen Hsieh
Rankless by CCL
2026